Study Title
Study Details
Description:
This is a dual arm, single centre, investigator initiated study to investigate the use of FAZA-PET in combination with MRI. FAZA is an investigational radiotracer used in PET scans. FAZA PET/MRI will be used to measure hypoxia in sarcoma tissues and will occur for: Arm A: before neo-adjuvant radiation/chemotherapy treatment; Arm B: before surgery (optional). After the FAZA PET/MRI scan, patients will be followed up via telephone, 48 hours after the scan, to see if there are any side effects due to FAZA. Up to 20 patients enrolled in Arm B will receive pimonidazole approximately 16-20 hours before surgery.
Sponsor:
University Health Network, Toronto
Contacts:
David Shultz, MDdavid.shultz@rmp.uhn.ca
416-946-4501 ext 2127
Government Study Link:
NCT03418818 - Click here to see study onClinicalTrials.gov